No definition available.
Endpoint definition
↥Report an error or suggest an improvement for this endpoint codes
Endpoint definition steps |
FinnGen |
|---|---|
Phenotype data |
519870 |
1. Apply sex-specific ruleonly females |
293145 |
2. Check conditionsNone |
293145 |
3. Check pre-conditions, main-only, mode, registry filtersRegistry filters:
3 out of 7 registries used, show all original rules. |
321 |
4. Check minimum number of eventsNone |
321 |
5. Include endpointsNone |
321 |
6. Filter based on genotype QC (FinnGen only) |
309 |
Control definitions (FinnGen only)
- Control exclude
- C3_CANCER, C3_CANCER_WIDE
Extra metadata
- First used in FinnGen datafreeze
- DF12
Similar endpoints
↥List of similar endpoints to
Endometroid carcinoma of ovary, including Hilmo
based on the number of shared cases.
Similar with more cases:
- Malignant neoplasm of ovary, including Hilmo
- malignant neoplasm of female genital organs, including Hilmo
- Solid cancers, including Hilmo
- Malignant neoplasm, wide definition
- Malignant neoplasm, including Hilmo
Similar with less cases:
Case counts by codes
↥
Summary Statistics
↥-FinRegistry-
This endpoint is excluded (different definition than used in FinnGen).
-FinnGen-
Key figures
| All | Female | Male | |
|---|---|---|---|
| Number of individuals | 309 | 309 | - |
| Unadjusted period prevalence (%) | 0.11 | 0.11 | - |
| Median age at first event (years) | 59.54 | 59.54 | - |
-FinnGen-
Age distribution of first events
-FinnGen-
Year distribution of first events
-FinnGen-
Cumulative Incidence Function
No data
CodeWAS
↥CodeWAS is a tool for exploring the associations between an endpoint and all of the medical codes and drug codes.
This is a new tool, please reach out using the contact form for feedback and improvement ideas.
First, a cohort is built by matching controls to the endpoint cases using year of birth and sex. Then, a Fisher test is done for all the medical codes and drug codes between the cases and controls of this cohort. Codes are reported in the table below if they have −log10(p-value) ≥ 6.
Matched cohort
- Matched cases
- 321
- Matched controls
- 3210
Code
Vocabulary
Description
Odds Ratio
-log10(p)
N matched cases
N matched controls
H02AB02
ATC
dexamethasone; systemic
182.0
307.7
175
21
C56.73
ICD-10 Finland
Endomeroid epithelial carcinoma of the ovary
+∞
307.7
278
*
8380/3-C56.9
ICD-O-3
Endometrioid adenocarcinoma, NOS, of ovary
+∞
273.7
222
*
A04AA01
ATC
ondansetron; systemic, rectal
58.5
237.5
144
44
128
Kela drug reimbursment
Cancers of female genital organs
+∞
218.6
184
*
D39.10
ICD-10 Finland
Tumor of uncertain or unknown nature in the ovary without histology
53.4
196.4
119
35
A03FA01
ATC
metoclopramide; systemic, rectal
21.6
178.5
226
318
WX302
NOMESCO Finland
Thoracal epidural anesthesy
54.1
177.4
106
29
LAF16
NOMESCO Finland
Excision of uterus, adnexes and lymph nodes for treatment of ovarian cancer
+∞
155.2
136
*
JEA00
NOMESCO Finland
Appendectomy
23.4
136.8
112
72
JN4BD
NOMESCO Finland
Extensive body CT
24.5
123.0
96
55
WX602
NOMESCO Finland
Repeated or continuing anesthesia shots throug a catheter
16.1
108.2
108
98
R19.0
ICD-10 Finland
Intra-abdominal and pelvic swelling, mass and lump
25.7
106.9
80
41
C56.71
ICD-10 Finland
Serous epithelial malignant tumor of the ovary
+∞
105.1
95
*
C56
ICD-10 Finland
Malignant neoplasm of ovary
+∞
105.1
95
*
WB113
NOMESCO Finland
Multiple adjuvant cytostatic therapy
+∞
99.2
90
*
JAL30
NOMESCO Finland
Omentectomy
213.8
92.7
92
6
B01AB10
ATC
tinzaparin; parenteral
11.3
92.1
122
165
LX1XE
NOMESCO Finland
Other gynecological ultrasound examination
18.4
89.2
78
55
C56.00
ICD-10 Finland
Malignant tumor of the ovary without histology
+∞
83.0
76
*
JN4AD
NOMESCO Finland
Body CT examination
12.8
81.5
91
96
LAF10
NOMESCO Finland
Bilateral salpingo-oophorectomy
15.0
75.7
74
63
L03AA13
ATC
pegfilgrastim; parenteral
672.1
58.6
56
*
WD125
NOMESCO Finland
Demanding cystostatic therapy of methastized malignancy
600.4
53.1
51
*
Z51.5
ICD-10 Finland
Palliative care
11.3
50.1
57
60
WD105
NOMESCO Finland
Cystostatic therapy of methastized malignancy
544.8
48.7
47
*
A04AA02
ATC
granisetron; systemic, transdermal
531.2
47.6
46
*
A04AA55
ATC
palonosetron, combinations; systemic
+∞
44.9
42
*
WB123
NOMESCO Finland
Demanding adjuvant cytostatic therapy
+∞
44.9
42
*
L02BG04
ATC
letrozole; oral
82.1
44.4
49
7
LCD00
NOMESCO Finland
Hysterectomy
8.0
43.6
67
103
L03AA14
ATC
lipegfilgrastim; parenteral
+∞
42.7
40
*
TPH07
NOMESCO Finland
Cathetrisation of artery
6.4
42.5
85
172
C54.11
ICD-10 Finland
Adenocarcinoma of the endometrium
+∞
41.6
39
*
PJD54
NOMESCO Finland
Block dissection of iliac lymph nodes
+∞
41.6
39
*
L03AA02
ATC
filgrastim; parenteral
+∞
41.6
39
*
XF603
NOMESCO Finland
Direct intraarterial blood pressure measurement
10.5
40.6
48
53
WZC20
NOMESCO Finland
Multidisciplinary treatment meeting
14.2
39.9
38
30
JAH00
NOMESCO Finland
Laparotomy
16.2
39.7
35
24
XLD00
NOMESCO Finland
Sytologyspecimen from mouth of uterus
5.1
36.8
98
254
WF049
NOMESCO Finland
Radiotherapy of metastasis
+∞
36.1
34
*
A04AA03
ATC
tropisetron; systemic
387.4
35.7
35
*
C56.98
ICD-10 Finland
Malignant tumor of the ovary, indeterminate histology
+∞
35.0
33
*
WB103
NOMESCO Finland
Simple adjuvant cytostatic therapy
+∞
35.0
33
*
TLE20
NOMESCO Finland
Transvaginal puncture of cul-de-sac
370.5
33.5
33
*
B01AB05
ATC
enoxaparin; parenteral
3.9
32.9
170
712
ZXE20
NOMESCO Finland
More than three and less than five hours
5.1
32.3
83
207
Z31.5
ICD-10 Finland
Genetic counselling
9.0
31.9
42
53
C79.8
ICD-10 Finland
Secondary malignant neoplasm of other specified sites
+∞
31.8
30
*
WW500
NOMESCO Finland
Blood transfusion
13.1
31.2
31
26
LC2BE
NOMESCO Finland
Transvaginal ultrasound examination of uterus, parametria and lower abdomen
3.8
30.7
174
766
JAL00
NOMESCO Finland
Biopsy of peritoneum
91.7
30.4
33
*
1830A
ICD-9 Finland
Malignant neoplasm of ovary and other uterine adnexa, Ovary
+∞
29.6
28
*
130
Kela drug reimbursment
Malignant tumour
+∞
29.6
28
*
8380/3-C54.1
ICD-O-3
Endometrioid adenocarcinoma, NOS, of endometrium
+∞
28.6
27
*
C56.79
ICD-10 Finland
Other epithelial carcinoma of the ovary
+∞
28.6
27
*
LX1AE
NOMESCO Finland
Gynecological ultrasound examination as part of clinical examination
4.6
28.3
80
214
HA1AA
NOMESCO Finland
X-ray mammography
6.5
27.7
49
86
WZC00
NOMESCO Finland
Treatment plan or consultation
3.5
27.1
150
639
ZX120
NOMESCO Finland
Intravenous
6.4
26.6
48
86
PJD53
NOMESCO Finland
Block dissection of aortic lymph nodes
+∞
26.4
25
*
WD115
NOMESCO Finland
Multiple cystostatic therapy of methastized malignancy
+∞
26.4
25
*
PJA12
NOMESCO Finland
Sentinel node biopsy
+∞
26.4
25
*
WD405
NOMESCO Finland
Simple antiboidy therapy of methastized malignancy
282.1
26.1
26
*
115
Kela drug reimbursment
Breast cancer
+∞
25.3
24
*
JN3BD
NOMESCO Finland
Extensive abdominal CT
4.6
24.3
68
179
HA1AE
NOMESCO Finland
Ultrasound examination of mammary glands
6.8
22.9
38
62
WX402
NOMESCO Finland
General anaesthesia
3.6
22.7
99
356
LC2AE
NOMESCO Finland
Ultrasound examination of uterus and parametria
4.1
22.4
72
210
JAL20
NOMESCO Finland
Excision or destruction of lesion of peritoneum
86.3
22.0
24
*
L02BA01
ATC
tamoxifen; oral
+∞
21.1
20
*
C56.72
ICD-10 Finland
Mucinous epithelial carcinoma of the ovary
+∞
21.1
20
*
PJD64
NOMESCO Finland
Laparoscopic dissection of iliac lymph nodes
+∞
21.1
20
*
PJD63
NOMESCO Finland
Laparoscopic dissection of aortic lymph nodes
+∞
20.0
19
*
N02AB03
ATC
fentanyl; nasal, sublingual, transdermal
8.8
19.9
26
32
ZX012
NOMESCO Finland
Radiotherapy with large shaped fields - isocentric therapy
112.0
19.8
21
*
Z08.7
ICD-10 Finland
Follow-up examination after combined treatment for malignant neoplasm
212.6
19.8
20
*
XX3DW
NOMESCO Finland
Time consuming IT work
5.7
19.6
39
76
JAL31
NOMESCO Finland
Laparoscopic omentectomy
+∞
18.9
18
*
X77
ICPC
Malignant neopl genital female other
+∞
18.9
18
*
Z51.1
ICD-10 Finland
Chemotherapy session for neoplasm
+∞
18.9
18
*
C78.6
ICD-10 Finland
Secondary malignant neoplasm of retroperitoneum and peritoneum
+∞
18.9
18
*
K43.9
ICD-10 Finland
Other and unspecified ventral hernia without obstruction or gangrene
6.0
18.8
35
64
N02AA05
ATC
oxycodone; systemic
3.2
18.5
91
349
R18
ICD-10 Finland
Ascites
21.6
18.1
26
13
8461/3-C56.9
ICD-O-3
High grade serous carcinoma of ovary
+∞
17.9
17
*
D39.9
ICD-10 Finland
Neoplasm of uncertain or unknown behaviour: Female genital organ, unspecified
44.8
17.5
21
5
C50.41
ICD-10 Finland
Malignant tumor of the upper outer quadrant of the mammary gland, ductal tumor
+∞
16.8
16
*
LC2DE
NOMESCO Finland
Demanding ultrsound examination of uterus, parametrium and lower part of abdomen with speciel methods
5.8
16.7
32
60
D70.82
ICD-10 Finland
Drug-induced neutropenia
178.9
16.7
17
*
JAH01
NOMESCO Finland
Laparoscopy
5.8
16.2
31
58
WX404
NOMESCO Finland
Intravenous generell anesthesy
3.0
16.2
89
361
JAP00
NOMESCO Finland
Freeing of adhesions in the peritoneal cavity
23.5
15.8
22
10
C567, ,
ICD-10 Finland
+∞
15.8
15
*
WC125
NOMESCO Finland
Demanding cytostatic therapy of local tumor recidive
+∞
15.8
15
*
C78.7
ICD-10 Finland
Secondary malignant neoplasm of liver and intrahepatic bile duct
+∞
15.8
15
*
WC115
NOMESCO Finland
Cytostatic therapy of local tumor recidive with multiple drugs
+∞
15.8
15
*
LAF11
NOMESCO Finland
Laparoscopic bilateral salpingo-oophorectomy
4.6
15.5
39
93
JF1AB
NOMESCO Finland
Passage examination of small bowell with X-ray
18.6
14.0
21
12
C44.31
ICD-10 Finland
Basocellular carcinoma of the skin on another or unspecified part of the face
55.9
13.9
16
*
ZXE30
NOMESCO Finland
More than five and less than seven hours
6.1
13.9
25
44
JA2AT
NOMESCO Finland
Abdominal puncture with ultrasound guidance
35.8
13.6
17
5
8500/3-C50.9
ICD-O-3
Infiltrating duct carcinoma, NOS, of breast, NOS
+∞
13.6
13
*
WF004
NOMESCO Finland
Palliative radiotherapy
+∞
13.6
13
*
WD135
NOMESCO Finland
Demanding cystostatic therapy of methastized malignancy
+∞
13.6
13
*
L02AB02
ATC
medroxyprogesterone; systemic
27.1
13.5
18
7
N80.1
ICD-10 Finland
Endometriosis of ovary
6.1
13.4
24
42
8090/3-C44.9
ICD-O-3
Basal cell carcinoma, NOS, of skin, NOS
+∞
12.6
12
*
WC105
NOMESCO Finland
Simple cytostatic therapy of local tumor recidive
+∞
12.6
12
*
A79
ICPC
Malignancy NOS
135.1
12.5
13
*
KBV02
NOMESCO Finland
Cystoscopic insertion of stent into ureter
12.3
12.5
22
19
K56.6
ICD-10 Finland
Other and unspecified intestinal obstruction
11.2
12.5
23
22
ZXC40
NOMESCO Finland
Use of ultrasound
39.2
12.3
15
*
D39.19
ICD-10 Finland
Tumor of uncertain or unknown nature in the ovary with unspecified histology
22.3
12.1
17
8
JFB46
NOMESCO Finland
Resection of sigmoid colon
24.0
11.7
16
7
HA003
NOMESCO Finland
Radiotherapy after partial ablation of mammary gland
+∞
11.5
11
*
C56.74
ICD-10 Finland
Mesonephroid epithelial carcinoma of the ovary
+∞
11.5
11
*
8441/3-C56.9
ICD-O-3
Serous carcinoma, NOS, of ovary
+∞
11.5
11
*
HAC20
NOMESCO Finland
Total mastectomy
+∞
11.5
11
*
HAB40
NOMESCO Finland
Wedge excision of mammary gland
26.1
11.2
15
6
121
Kela drug reimbursment
Severe hypofunction of sexual glands
5.7
11.0
21
39
N13.3
ICD-10 Finland
Other and unspecified hydronephrosis
12.5
11.0
19
16
Z80.3
ICD-10 Finland
Family history of malignant neoplasm of breast
18.6
10.8
16
9
JN3AE
NOMESCO Finland
Abdominal ultrasound examination
3.1
10.8
51
187
JA3AT
NOMESCO Finland
Cathetrisation of abdominal cavity with ultrasound guidance
22.4
10.8
15
7
JN3AD
NOMESCO Finland
Abdominal CT examination
2.9
10.7
56
218
R2110
NOMESCO Finland
Giving the first information
3.6
10.5
37
113
L01BC06
ATC
capecitabine; oral
+∞
10.5
10
*
YL1BD
NOMESCO Finland
Extensive CT examination of pelvis for dose design of radiotherapy
+∞
10.5
10
*
JAQ00
NOMESCO Finland
Extensive excision of peritoneum
+∞
10.5
10
*
YG1AD
NOMESCO Finland
CT examination of thorax for dose design of radiotherapy
+∞
10.5
10
*
PJD43
NOMESCO Finland
Excision of aortic lymph nodes
+∞
10.5
10
*
I89.0
ICD-10 Finland
Lymphoedema, not elsewhere classified
24.3
10.3
14
6
K56.5
ICD-10 Finland
Intestinal adhesions [bands] with obstruction
15.2
10.1
16
11
B01AB04
ATC
dalteparin; parenteral
4.2
10.1
28
72
TPX10
NOMESCO Finland
Implantation of vascular injection port
10.0
9.9
19
20
Z08.0
ICD-10 Finland
Follow-up examination after surgery for malignant neoplasm
102.9
9.5
10
*
PJD44
NOMESCO Finland
Excision of iliac lymph nodes
102.9
9.5
10
*
JN1AE
NOMESCO Finland
Ultrasound examination of upper part of abdomen
3.1
9.4
41
143
PJD52
NOMESCO Finland
Block dissection of axillary lymph nodes
+∞
9.4
9
*
WF003
NOMESCO Finland
Adjuvant radiotherapy
+∞
9.4
9
*
L01CB01
ATC
etoposide; systemic
+∞
9.4
9
*
K56.7
ICD-10 Finland
Ileus, unspecified
11.1
9.4
17
16
WX306
NOMESCO Finland
Lumbar epidural anesthesy
3.7
9.3
31
91
WF002
NOMESCO Finland
Radical radiotherapy
37.8
9.1
11
*
JAD11
NOMESCO Finland
Laparoscopic repair of incisional hernia
13.0
9.0
15
12
WD415
NOMESCO Finland
Demanding antibody therapy of methastized malignancy
51.4
8.7
10
*
JN3DG
NOMESCO Finland
Very extensive MRI examination with high intensity magnet
51.4
8.7
10
*
JN2DG
NOMESCO Finland
Very extensive MRI examination of lower part of abdoment with high intensity magnet
20.7
8.5
12
6
WX408
NOMESCO Finland
General anesthesy, balanced
2.2
8.4
85
448
8440/3-C56.9
ICD-O-3
Cystadenocarcinoma, NOS, of ovary
+∞
8.4
8
*
Z85.4
ICD-10 Finland
Personal history of malignant neoplasm of genital organs
+∞
8.4
8
*
YX9AD
NOMESCO Finland
Other CT eamination for dose design of radiotherapy
+∞
8.4
8
*
18301
ICD-8 Finland
Malignant neoplasm of ovary, Fallopian tube and broad ligament, Ovary
+∞
8.4
8
*
YG1BD
NOMESCO Finland
Extensive CT examination of thorax for dose design of radiotherapy
+∞
8.4
8
*
C78.0
ICD-10 Finland
Secondary malignant neoplasm of lung
+∞
8.4
8
*
WB401
NOMESCO Finland
Simple antibody therapy of primary tumour
+∞
8.4
8
*
JAL01
NOMESCO Finland
Laparoscopic biopsy of peritoneum
+∞
8.4
8
*
166
Kela drug reimbursment
Dalteparin and tinzaparin (treatment for more than 6 months)
+∞
8.4
8
*
T81.4
ICD-10 Finland
Infection following a procedure, not elsewhere classified
2.7
8.1
46
186
FB1BD
NOMESCO Finland
Extensive CT examination of arteria pulmonalis
3.2
8.1
34
116
N02AX02
ATC
tramadol; systemic, rectal
2.0
8.0
158
1062
A49.9
ICD-10 Finland
Bacterial infection, unspecified
2.9
7.9
39
146
D39.0
ICD-10 Finland
Neoplasm of uncertain or unknown behaviour: Uterus
46.1
7.7
9
*
N95.1
ICD-10 Finland
Menopausal and female climacteric states
0.2
7.7
8
365
I26.9
ICD-10 Finland
Pulmonary embolism without mention of acute cor pulmonale
3.5
7.7
27
82
GA4YT
NOMESCO Finland
Puncture of pleura with ultrasound guidance
8.4
7.7
16
20
KH1BT
NOMESCO Finland
Urinary tract cathetrisation with X-ray guidance
18.9
7.7
11
6
T81.3
ICD-10 Finland
Disruption of operation wound, not elsewhere classified
8.0
7.5
16
21
JAW96
NOMESCO Finland
Other operation on abdominal wall, peritoneum, mesentery or omentum
81.9
7.4
8
*
JFF23
NOMESCO Finland
Transversostomy
81.9
7.4
8
*
HA6AA
NOMESCO Finland
Extra corporeal mammography of operated mammary gland
13.8
7.4
12
9
JN4CD
NOMESCO Finland
Very extensive body CT
9.7
7.4
14
15
D05.1
ICD-10 Finland
Intraductal carcinoma in situ
+∞
7.3
7
*
C50.21
ICD-10 Finland
Malignant tumor of the upper inner quadrant of the mammary gland,ductal tumor
+∞
7.3
7
*
8205
FHL
Subradical ovarian malignancy removal (includes possible genital and omet removal)
+∞
7.3
7
*
L02BG03
ATC
anastrozole; oral
+∞
7.3
7
*
WB121
NOMESCO Finland
Demanding neoadjuvant cytostatic therapy
+∞
7.3
7
*
8102
FHL
Second look"" surgery for a malignant tumor
+∞
7.3
7
*
C50.49
ICD-10 Finland
Malignant tumor of the upper outer quadrant of the mammary gland, other or undeterminated histology
+∞
7.3
7
*
C50
ICD-10 Finland
Malignant neoplasm of breast
+∞
7.3
7
*
JN3AA
NOMESCO Finland
Abdominal X-ray examination without contrast
4.0
7.1
20
52
QAE10
NOMESCO Finland
Excision of other lesion extending through all layers of skin in head or neck
3.9
6.7
20
54
GD1AA
NOMESCO Finland
Thorax X-ray examination
1.8
6.6
160
1128
TJA10
NOMESCO Finland
Laparocentesis
71.2
6.4
7
*
R50.9
ICD-10 Finland
Fever, unspecified
2.4
6.4
49
228
PH2AE
NOMESCO Finland
Ultrasound examination of lower leg veins
2.3
6.4
49
229
JFB00
NOMESCO Finland
Partial resection of small intestine
11.3
6.3
11
10
L02BG06
ATC
exemestane; oral
+∞
6.3
6
*
A04AD12
ATC
aprepitant; systemic
+∞
6.3
6
*
YL1AD
NOMESCO Finland
CT examination of pelvis for dose design of radiotherapy
+∞
6.3
6
*
PJ3AT
NOMESCO Finland
Cytology of lymphnode with ultrasound guidance
+∞
6.3
6
*
TQW20
NOMESCO Finland
Tatoe
+∞
6.3
6
*
8140/3-C56.9
ICD-O-3
Adenocarcinoma, NOS, of ovary
+∞
6.3
6
*
C50.40
ICD-10 Finland
Malignant tumor of the upper outer quadrant of the mammary gland, no histological veryfication
+∞
6.3
6
*
C50.42
ICD-10 Finland
Malignant tumor of the upper outer quadrant of the mammary gland, lobular tumor
+∞
6.3
6
*
WB203
NOMESCO Finland
Simple adjuvant hormone therapy of malignancy
+∞
6.3
6
*
C50.99
ICD-10 Finland
Breast, unspecified
+∞
6.3
6
*
8500/2-C50.9
ICD-O-3
Intraductal carcinoma, noninfiltrating, NOS, of breast, NOS
+∞
6.3
6
*
C64.88
ICD-10 Finland
Other malignant neoplasm of kidney, except renal pelvis
+∞
6.3
6
*
JBA10
NOMESCO Finland
Transabdominal biopsy or excision of lesion of diaphragm
+∞
6.3
6
*
D39.1
ICD-10 Finland
Neoplasm of uncertain or unknown behaviour: Ovary
10.3
6.1
11
11
LabWAS
↥
OMOP Concept
People with measurements
Mean N measurements
Mean measured value
(ID) Name
N Cases
N Controls
OR
-log10(p)
cases
controls
cases
controls
unit
-log10(p)
N cases
N controls
209
165
34.44
240.89
13.5
1.5
43.19
25.12
u/ml
0.95
203
159
124
167
11.47
94.09
3.4
1.5
4.63
2.60
ug/l
1.01
97
125
143
627
3.31
24.05
2.3
1.9
—
—
—
0
0
95
323
3.76
23.87
9.1
5.5
0.87
1.33
mmol/l
0.54
82
273
213
1232
3.17
21.35
2.9
2.3
—
—
estimate
—
0
0
39
71
6.11
21.11
3.2
1.9
35.71
14.40
u/ml
1.60
31
61
217
1280
3.15
20.78
5.5
3.6
34.26
35.98
g/l
4.40
209
1184
222
1435
2.77
16.03
10.9
3.4
10.16
10.52
umol/l
0.11
214
1346
225
1510
2.64
14.27
18.8
6.2
3.57
4.16
e9/l
4.87
192
1297
17
13
13.73
10.28
1.0
1.4
—
—
—
0
0
48
178
2.99
9.94
13.6
6.9
0.74
0.66
%
0.77
48
178
30
85
3.79
9.47
6.8
3.9
3.74
3.82
mmol/l
0.38
30
85
48
184
2.89
9.36
13.3
6.8
1.40
1.35
%
0.17
48
184
246
2842
0.42
8.84
5.1
5.5
4.88
4.78
mmol/l
0.75
231
2617
76
379
2.32
8.61
11.6
4.9
104.03
103.91
mmol/l
0.08
76
379
(3020427) Coagulation factor X inhibitor [Units/volume] in Platelet poor plasma by Coagulation assay
24
63
4.04
8.41
4.0
2.8
0.35
0.45
iu/ml
—
10
46
246
2824
0.45
7.83
4.9
5.4
1.63
1.60
mmol/l
0.43
225
2589
255
2883
0.44
7.52
5.8
6.4
2.78
2.74
mmol/l
0.30
235
2651
181
1312
1.87
6.95
14.3
14.6
1.21
1.24
inr
0.34
147
1092
16
24
6.96
6.90
1.0
2.0
3.56
156.79
u/ml
0.48
16
24
47
209
2.46
6.80
5.4
4.6
7.42
10.03
mmol/l
2.68
47
194
134
892
1.86
6.67
5.5
2.5
28.77
29.38
u/l
0.11
128
841
262
2184
2.09
6.16
11.9
5.4
81.48
75.78
u/l
2.26
248
2021
185
1387
1.79
6.02
8.3
5.0
1.18
1.22
mmol/l
8.44
178
1254
252
2829
0.49
5.89
5.2
5.6
5.93
5.92
mmol/l
0.04
230
2587
246
2775
0.51
5.55
5.9
6.3
1.81
1.92
mu/l
0.82
228
2573
242
2743
0.52
5.53
6.4
6.9
39.51
39.61
mmol/mol
0.06
220
2562
101
651
1.80
5.36
2.0
1.6
1.59
1.10
mg/l
1.40
86
517
55
299
2.01
4.87
2.3
2.1
4.07
5.15
umol/l
2.41
47
259
206
1653
1.69
4.73
5.4
4.4
0.00
0.02
estimate
0.96
32
318
195
1548
1.66
4.61
8.3
5.6
1.18
1.22
mmol/l
9.06
179
1341
139
1013
1.66
4.61
3.8
3.4
—
—
—
0
0
213
2468
0.59
4.46
4.9
4.9
14.78
14.96
pmol/l
0.49
191
2277
40
200
2.14
4.41
1.4
1.5
—
—
—
0
0
34
162
2.23
4.22
10.9
6.6
24.47
25.58
mmol/l
0.99
34
162
241
2697
0.57
4.21
4.1
4.6
1.27
1.25
mmol/l
0.25
213
2440
79
506
1.74
4.17
2.8
3.0
1.46
1.73
e6/l
0.22
36
267
112
799
1.62
3.91
3.0
3.3
0.52
0.46
e6/l
0.11
76
598
95
1279
0.63
3.38
2.2
1.9
1.38
1.30
mmol/l
0.38
83
1086
18
71
2.63
3.35
3.2
3.4
2.80
0.58
index
—
10
31
8
15
5.44
3.21
1.4
1.5
—
—
—
0
0
67
442
1.65
3.13
2.9
3.2
6.20
4.44
e6/l
0.31
26
198
46
273
1.80
3.12
1.8
2.2
26.76
38.51
u/l
1.39
37
222
8
16
5.10
3.07
1.4
1.1
270.50
260.06
u/l
—
8
16
285
3011
0.52
3.05
42.0
21.8
4.17
4.39
e12/l
12.47
279
2926
20
409
0.46
3.04
3.9
5.4
29.10
34.09
%
—
10
257
47
724
0.59
2.86
1.2
1.3
0.56
2.14
u/ml
—
8
195
84
604
1.53
2.71
1.3
1.4
—
—
—
0
0
122
948
1.46
2.69
2.9
2.2
83.88
58.39
u/l
0.47
113
860
138
1099
1.45
2.67
5.3
2.1
2.36
2.37
mmol/l
0.48
130
959
27
143
1.97
2.60
1.7
1.5
—
—
—
0
0
123
1515
0.70
2.54
2.6
2.5
81.17
81.15
nmol/l
0.00
110
1343
47
299
1.67
2.52
3.7
2.8
1.84
2.30
mmol/l
0.27
42
268
33
190
1.82
2.49
4.2
3.1
4.43
4.42
pmol/l
0.03
33
169
11
38
2.96
2.44
1.1
1.3
—
—
—
0
0
199
2242
0.70
2.35
4.6
4.8
16.27
12.76
mm/h
2.29
181
2077
76
1010
0.68
2.32
2.1
2.1
96.60
162.64
u/l
2.25
68
961
16
73
2.25
2.25
2.9
3.1
—
—
—
0
0
190
1647
1.38
2.08
5.7
4.4
0.00
0.00
estimate
-0.00
33
330
12
50
2.45
2.05
1.3
1.2
—
—
—
0
0
186
1623
1.35
1.86
5.7
4.4
0.00
0.00
estimate
-0.00
29
316
5
12
4.21
1.83
1.4
1.3
—
—
—
0
0
18
95
1.95
1.79
1.4
1.6
—
—
—
0
0
8
31
2.62
1.67
1.4
1.3
—
—
—
0
0
5
14
3.61
1.62
1.4
1.2
—
—
—
0
0
5
14
3.61
1.62
1.4
1.2
—
—
—
0
0
10
43
2.37
1.60
1.4
1.2
—
—
—
0
0
283
2945
0.67
1.43
20.6
10.6
23.42
22.38
u/l
0.59
277
2831
126
1459
0.78
1.42
2.3
2.2
84.45
100.55
pmol/l
2.37
57
675
9
40
2.29
1.41
1.3
1.1
—
—
—
0
0
46
335
1.44
1.39
1.9
1.8
—
—
—
0
0
33
468
0.67
1.36
1.5
1.5
—
—
—
0
0
8
35
2.32
1.27
1.0
1.2
—
—
—
0
0
34
239
1.47
1.24
3.1
2.1
54.48
67.09
ml/min/173m2
1.52
21
100
47
614
0.73
1.23
1.3
1.3
41.60
12.87
u/ml
0.46
12
229
0
35
0.00
1.16
0.0
1.1
—
2.26
—
0
5
11
58
1.93
1.13
1.3
1.2
—
—
—
0
0
26
179
1.49
1.07
4.3
2.2
1.28
1.19
%
0.26
26
179
26
179
1.49
1.07
4.3
2.2
0.59
0.63
%
0.27
26
179
19
286
0.64
1.06
3.8
3.1
121.84
77.33
ng/l
0.77
19
246
9
47
1.94
1.03
1.0
1.4
—
—
—
0
0
9
47
1.94
1.03
1.0
1.4
—
—
—
0
0
5
109
0.45
1.02
1.2
1.4
—
6.67
—
0
29
5
109
0.45
1.02
1.2
1.3
—
2.44
—
0
18
58
466
1.30
0.98
1.8
1.8
—
—
—
0
0
13
78
1.69
0.93
1.3
1.6
—
—
—
0
0
97
1112
0.82
0.90
3.9
3.8
10.80
7.43
mg/mmol
0.33
57
630
125
1397
0.83
0.89
3.3
3.0
121.90
90.23
ug/l
1.23
117
1292
6
30
2.02
0.87
1.2
1.3
—
—
—
0
0
6
113
0.52
0.84
1.2
1.3
—
20.09
—
0
8
9
149
0.59
0.81
1.0
1.7
—
—
—
0
0
5
97
0.51
0.79
1.0
1.8
—
—
—
0
0
0
25
0.00
0.79
0.0
1.4
—
1.46
—
0
11
0
25
0.00
0.79
0.0
1.4
—
1.34
—
0
11
0
25
0.00
0.79
0.0
1.4
—
0.97
—
0
11
11
67
1.66
0.76
1.5
1.5
—
—
—
0
0
44
354
1.28
0.76
2.0
1.8
—
—
—
0
0
9
55
1.65
0.74
1.2
1.2
—
—
—
0
0
49
589
0.80
0.71
1.5
1.7
1323.89
1221.71
nmol/l
0.29
37
434
87
987
0.84
0.71
1.9
1.7
24.15
21.81
nmol/l
0.64
75
820
131
1189
1.17
0.69
4.4
3.9
26.59
60.01
ng/l
0.61
95
860
70
601
1.21
0.69
5.1
4.5
19.93
219.17
ng/l
1.38
57
477
7
42
1.68
0.69
1.6
1.3
—
—
—
0
0
101
1125
0.85
0.66
3.2
3.2
6.23
6.23
mmol/l
0.00
79
950
145
1566
0.86
0.62
2.6
2.7
—
—
—
0
0
0
20
0.00
0.60
0.0
1.1
—
—
—
0
0
0
22
0.00
0.59
0.0
1.6
—
28.00
—
0
5
19
252
0.74
0.59
1.5
1.5
—
—
—
0
0
134
1233
1.15
0.57
5.2
4.3
0.28
0.05
estimate
0.80
29
251
6
37
1.63
0.56
1.3
1.1
—
—
—
0
0
6
38
1.59
0.54
1.5
1.2
—
—
—
0
0
234
2247
1.15
0.51
34.0
17.8
14.38
13.62
%
10.08
234
2215
57
646
0.86
0.46
1.3
1.3
13.75
37.02
iu/ml
4.14
12
201
83
754
1.14
0.42
5.5
4.6
1.02
1.02
kg/l
0.36
59
487
0
15
0.00
0.41
0.0
1.3
—
—
—
0
0
0
16
0.00
0.41
0.0
1.8
—
—
—
0
0
0
16
0.00
0.41
0.0
1.1
—
—
—
0
0
0
16
0.00
0.41
0.0
1.1
—
—
—
0
0
0
16
0.00
0.41
0.0
1.8
—
—
—
0
0
(3016894) Varicella zoster virus DNA [Presence] in Cerebral spinal fluid by NAA with probe detection
0
17
0.00
0.41
0.0
1.1
—
—
—
0
0
0
17
0.00
0.41
0.0
1.1
—
11.48
—
0
9
0
17
0.00
0.41
0.0
1.4
—
—
—
0
0
8
60
1.34
0.40
1.0
1.1
—
—
—
0
0
0
18
0.00
0.40
0.0
1.2
—
—
—
0
0
0
18
0.00
0.40
0.0
1.1
—
—
—
0
0
5
35
1.44
0.39
1.2
1.2
—
—
—
0
0
5
35
1.44
0.39
1.0
1.2
—
—
—
0
0
62
688
0.88
0.38
1.6
1.8
1176.80
10811284.99
pmol/l
0.50
45
555
5
76
0.65
0.36
1.8
1.4
—
—
—
0
0
9
122
0.73
0.36
1.1
1.4
—
—
—
0
0
6
45
1.34
0.34
1.2
1.5
—
—
—
0
0
171
1784
0.91
0.33
4.2
3.0
52.82
38.40
u/l
1.83
157
1647
7
100
0.69
0.31
1.0
1.2
—
—
—
0
0
73
674
1.11
0.29
3.1
2.2
2.48
2.46
mmol/l
0.82
67
604
44
395
1.13
0.28
12.8
6.6
—
—
—
0
0
8
65
1.24
0.27
1.4
1.5
—
—
—
0
0
8
66
1.22
0.27
1.1
1.3
1.68
1.63
g/l
—
8
66
31
273
1.15
0.26
2.6
3.4
—
—
—
0
0
6
85
0.70
0.24
1.2
1.3
—
62.05
—
0
11
20
171
1.18
0.24
1.3
1.7
—
—
—
0
0
106
1008
1.08
0.23
3.5
2.9
1684.66
1108.97
ng/l
0.42
95
853
0
11
0.00
0.21
0.0
1.2
—
—
—
0
0
0
10
0.00
0.21
0.0
1.2
—
—
—
0
0
0
10
0.00
0.21
0.0
1.2
—
—
—
0
0
0
10
0.00
0.21
0.0
1.3
—
—
—
0
0
0
12
0.00
0.21
0.0
1.2
—
100.56
—
0
12
0
12
0.00
0.21
0.0
2.0
—
—
—
0
0
0
12
0.00
0.21
0.0
1.0
—
0.53
—
0
6
0
12
0.00
0.21
0.0
1.1
—
—
—
0
0
0
13
0.00
0.21
0.0
1.0
—
10.35
—
0
13
0
13
0.00
0.21
0.0
1.0
—
—
—
0
0
267
2709
0.91
0.20
25.4
13.7
75.63
76.14
ml/min/173m2
0.15
252
2496
0
14
0.00
0.20
0.0
1.1
—
—
—
0
0
0
14
0.00
0.20
0.0
1.1
—
—
—
0
0
21
237
0.88
0.18
1.3
1.2
140.33
120.04
u/ml
—
9
105
13
152
0.85
0.17
1.0
1.1
—
—
—
0
0
12
101
1.20
0.17
2.0
1.8
2.70
59.11
iu/l
—
5
42
8
69
1.16
0.16
1.1
1.4
0.86
0.91
g/l
—
8
69
17
149
1.15
0.16
2.6
3.6
5.29
5.29
kpa
0.00
17
143
6
78
0.76
0.15
2.8
3.0
26.73
25.43
mmol/l
—
6
78
15
171
0.87
0.15
1.1
1.7
—
—
—
0
0
280
2773
1.08
0.13
23.3
14.0
33.55
20.78
mg/l
7.21
259
2224
13
113
1.16
0.13
1.6
1.5
—
—
—
0
0
81
779
1.05
0.12
2.3
2.4
3.21
2.95
mg/l
0.28
67
657
82
848
0.96
0.10
4.4
3.7
0.18
0.00
estimate
0.75
28
262
27
251
1.08
0.10
4.8
3.8
110.05
231.56
ng/l
1.44
21
231
22
237
0.92
0.09
2.5
2.1
3.40
3.26
ratio
0.26
17
197
6
54
1.11
0.09
2.3
2.7
14.75
16.11
%
—
6
54
5
61
0.82
0.08
1.6
1.7
—
—
—
0
0
89
912
0.97
0.07
5.7
4.4
0.04
0.00
estimate
0.49
27
306
10
89
1.13
0.07
1.6
1.5
—
—
—
0
0
68
690
0.98
0.02
2.0
2.1
311.53
325.56
umol/l
0.74
59
593
10
95
1.05
0.00
1.6
1.5
—
—
—
0
0
14
144
0.97
0.00
1.1
1.4
—
—
—
0
0
0
9
0.00
0.00
0.0
1.0
—
—
—
0
0
0
9
0.00
0.00
0.0
1.0
—
—
—
0
0
(3002348) Coagulation factor XII activity actual/normal in Platelet poor plasma by Coagulation assay
0
5
0.00
-0.00
0.0
1.2
—
—
—
0
0
0
5
0.00
-0.00
0.0
1.2
—
—
—
0
0
8
86
0.93
-0.00
1.0
1.2
—
—
—
0
0
0
7
0.00
-0.00
0.0
1.0
—
—
—
0
0
9
95
0.95
-0.00
2.1
1.7
108.11
327.35
ug/l
—
9
88
0
8
0.00
-0.00
0.0
1.3
—
189.42
—
0
8
9
96
0.94
-0.00
1.1
1.1
—
—
—
0
0
0
5
0.00
-0.00
0.0
1.2
—
—
—
0
0
7
79
0.88
-0.00
1.0
1.1
—
14.38
—
0
6
0
7
0.00
-0.00
0.0
1.0
—
—
—
0
0
9
96
0.94
-0.00
1.1
1.1
—
—
—
0
0
5
54
0.92
-0.00
1.0
1.2
0.18
0.18
nmol/l
—
5
39
0
5
0.00
-0.00
0.0
1.0
—
—
—
0
0
0
7
0.00
-0.00
0.0
1.0
—
—
—
0
0
0
5
0.00
-0.00
0.0
1.2
—
114.80
—
0
5
0
6
0.00
-0.00
0.0
1.2
—
111.83
—
0
6
0
7
0.00
-0.00
0.0
1.0
—
—
—
0
0
8
79
1.01
-0.00
1.5
1.4
—
—
—
0
0
0
5
0.00
-0.00
0.0
1.2
—
—
—
0
0
0
7
0.00
-0.00
0.0
1.0
—
—
—
0
0
0
5
0.00
-0.00
0.0
1.8
—
9.62
—
0
5
0
5
0.00
-0.00
0.0
1.8
—
4.47
—
0
5
0
7
0.00
-0.00
0.0
1.0
—
—
—
0
0
0
7
0.00
-0.00
0.0
1.1
—
0.16
—
0
7
0
7
0.00
-0.00
0.0
1.0
—
—
—
0
0
0
5
0.00
-0.00
0.0
1.0
—
—
—
0
0
0
8
0.00
-0.00
0.0
1.1
—
—
—
0
0
5
55
0.91
-0.00
1.0
1.3
—
—
—
0
0
0
6
0.00
-0.00
0.0
1.2
—
—
—
0
0
0
5
0.00
-0.00
0.0
1.0
—
—
—
0
0
5
59
0.85
-0.00
1.4
1.3
0.84
32.16
nmol/l
—
5
54
0
5
0.00
-0.00
0.0
1.2
—
—
—
0
0
0
7
0.00
-0.00
0.0
1.0
—
19.84
—
0
7
Mortality – FinRegistry
↥This endpoint is excluded (different definition than used in FinnGen).
Relationships between endpoints
↥Index endpoint: C3_OVARY_ENDOMETROID_WIDE – Endometroid carcinoma of ovary, including Hilmo
GWS hits: -
This endpoint is excluded (different definition than used in FinnGen).